DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Velcade (Bortezomib) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia (124)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 124   Next >>

Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient: male, weighing 103.1 kg (226.8 pounds)

Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Radiation Therapy NOS
    Indication: Multiple Myeloma

Revlimid
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide



Possible Velcade side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Neuropathy Peripheral, Pneumonia, Post Herpetic Neuralgia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-10-01

Velcade
    Dosage: 3.4 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-10-06
    End date: 2012-02-02

Other drugs received by patient: Simvastin-Mepha; Enalapril Maleate; Aspirin; Doxazosin Mesylate; Amlodipine; Dyazide



Possible Velcade side effects in

Reported by a physician from Netherlands on 2012-08-22

Patient:

Reactions: Pneumonia, Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 4000 mg/m2, unk
    Start date: 2012-02-03
    End date: 2012-02-03

Cyclophosphamide
    Dosage: 500 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-12-23
    End date: 2011-12-30

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-23
    End date: 2012-01-03

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-12-23
    End date: 2012-01-02

Other drugs received by patient: Tramal / 00599201 /; Acetaminophen; Ascal / 00002702 /; Oxycodone HCL; Fluconazole; Gabapentin; Persantine; Haldol; Omeprazole; Butrans; Fragmin; Esomeprazole Sodium; Pregabalin; Cotrim; Valaciclovir; Hydrochlorothiazide



Possible Velcade side effects in 70 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22

Patient: 70 year old male, weighing 104.3 kg (229.5 pounds)

Reactions: Pneumonia, Thrombocytopenia, Groin Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Torisel
    Dosage: 25 mg d1, d8 iv
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-07-30
    End date: 2012-08-06

Velcade
    Dosage: 3.6 mg d1, d8 iv
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2012-07-30
    End date: 2012-08-06



Possible Velcade side effects in

Reported by a physician from Turkey on 2012-08-21

Patient:

Reactions: Asthma, Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-12-22
    End date: 2012-03-12

Velcade
    Dosage: unk
    Start date: 2012-03-22

Other drugs received by patient: Tiotropium Bromide; Clarithromycin; Moxifloxacin; Tazobactam; Dexamethasone; Zometa; Ceftriaxone Sodium; Formoterol Fumarate; Methylprednisolone; Dexamethasone



Possible Velcade side effects in

Reported by a physician from Turkey on 2012-08-20

Patient:

Reactions: Asthma, Pneumonia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-12-22
    End date: 2012-03-12

Velcade
    Dosage: unk
    Start date: 2012-03-22

Other drugs received by patient: Dexamethasone; Dexamethasone; Tiotropium Bromide; Moxifloxacin; Tazobactam; Formoterol Fumarate; Zometa; Clarithromycin; Methylprednisolone; Ceftriaxone Sodium



Possible Velcade side effects in

Reported by a physician from Turkey on 2012-08-20

Patient:

Reactions: Pneumonia, Thrombocytopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-02-09
    End date: 2009-04-20

Velcade
    Dosage: 2.57 mg, unk
    Indication: Multiple Myeloma
    Start date: 2009-02-09
    End date: 2009-04-20



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: male

Reactions: Pneumonia, Sepsis, Hypoxia, Mastoiditis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 4 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-04-04

Dexamethasone
    Dosage: 4 mg, cyclic
    Start date: 2012-05-01

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Administration route: Oral
    Start date: 2012-05-01

Velcade
    Dosage: 1 mg/m2, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-04-04

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Start date: 2012-04-04

Other drugs received by patient: Epogen; Neupogen; Blood and Related Products; Levaquin; Lithium Carbonate; Amitriptyline HCL; Platelets; Vfend; Acyclovir; Androderm



Possible Velcade side effects in

Reported by a physician from Korea, Republic of on 2012-08-02

Patient:

Reactions: Pneumonia, Neutropenia, Thrombocytopenia, Septic Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 18 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-01-30

Melphalan Hydrochloride
    Dosage: 11 mg/m2, unk
    Start date: 2012-03-22
    End date: 2012-03-25

Prednisolone
    Dosage: 58 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-01-30

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-04-01



Possible Velcade side effects in

Reported by a physician from Germany on 2012-08-01

Patient:

Reactions: Renal Failure, Pneumonia, Pain, Urinary Retention, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Velcade
    End date: 2012-04-10

Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil



Possible Velcade side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26

Patient: 62 year old male, weighing 112.8 kg (248.2 pounds)

Reactions: Pneumonia, Musculoskeletal Chest Pain, RIB Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-21

Velcade
    Dosage: 3 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-03-21
    End date: 2012-03-31

Other drugs received by patient: Dilaudid; MS Contin; Restoril / 00393701 /; Crestor; Valaciclovir; Imodium; Hydromorphone HCL; Mepron / 01181501 /; Cholecalciferol; Clindamycin; Lyrica; Lasix; Ciproflaxacin; Fluconazole; Prilosec; Nystatin; Senokot; Zofran; Levalbuterol Hydrochloride; Prevident; Sucralfate; Diphenhydramine HCL; Maalox / 00082501 /



Possible Velcade side effects in

Reported by a physician from Japan on 2012-07-23

Patient:

Reactions: Pneumonia, C-Reactive Protein Increased, Dehydration, Atrial Fibrillation, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Panobinostat
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Velcade
    Dosage: 2.3 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Other drugs received by patient: Amlodipine; Candesartan Cilexetil; Mucosta; Warfarin Sodium



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-21

Patient: male, weighing 87.7 kg (192.9 pounds)

Reactions: Pneumonia, Haemoptysis, Hypotension, Hyponatraemia, Fall, Dehydration, Dizziness, Hypocalcaemia, Asthenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2011-05-17

Zometa
    Dosage: 2 mg, unk
    Indication: Bone Loss
    Start date: 2011-05-13

Other drugs received by patient: Decadron; Vicodin; Coumadin; Dulcolax; Fentanyl; Polyethylene Glycol; Fleet Enema / 00103901 /; Digoxin; Dexamethasone



Possible Velcade side effects in 76 year old male

Reported by a physician from France on 2012-07-19

Patient: 76 year old male, weighing 108.0 kg (237.6 pounds)

Reactions: Systemic Candida, General Physical Condition Abnormal, Pneumonia, Culture Stool Positive, Generalised Oedema, Renal Failure, Diarrhoea, Immunosuppression

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone TAB
    Dosage: 40 mg, oral
    Administration route: Oral
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-06

Doxorubicin HCL
    Dosage: 40 mg, intravenous
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-06

Rituximab (Rituximab) Suspension FOR Injection
    Dosage: 857 mg, intravenous
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-03

Velcade
    Dosage: 2 mg, intravenous
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-03



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore



Possible Velcade side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 500 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Velcade
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 milligram/sq. meter



Possible Velcade side effects in

Reported by a physician from Japan on 2012-07-17

Patient:

Reactions: Pneumonia, Pain, Atrial Fibrillation, Interstitial Lung Disease, C-Reactive Protein Increased, Dehydration, Dizziness, Thrombocytopenia, Decreased Appetite, Infection Susceptibility Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Panobinostat
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Velcade
    Dosage: 2.3 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Other drugs received by patient: Amlodipine; Candesartan Cilexetil; Warfarin Sodium; Mucosta



Possible Velcade side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carmustine
    Dosage: day - 7

Cytarabine
    Dosage: day -6 til day -3

Etoposide
    Dosage: day -6 till day -3

Melphalan Hydrochloride
    Dosage: day -2

Rituxan
    Dosage: day - 19 and day - 12

Velcade
    Dosage: d2 and d8
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-05-01

Vorinostat
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-30
    End date: 2012-05-06

Other drugs received by patient: Zovirax; Diphenhydramine HCL; Loperamide HCL; Dapsone; Compazine; Cholecalciferol; Allegra; Citalopram Hydrobromide; Bactrim; Potassium Chloride; Vitamin D (Unspecified); Potassium Bicarbonate; Nystatin; Lorazepam; Zofran; Folic Acid; Vitamins (Unspecified)



Possible Velcade side effects in female

Reported by a physician from United States on 2012-07-16

Patient: female, weighing 50.8 kg (111.7 pounds)

Reactions: Blood Calcium Decreased, Pneumonia, Platelet Count Decreased, Blood Magnesium Decreased, Clostridial Infection

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, 1/week
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-06-06

Revlimid
    Dosage: 25 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-06-05

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2012-05-01

Velcade
    Dosage: 0.1 mg, 1/week
    Start date: 2012-06-05

Other drugs received by patient: Zometa



Possible Velcade side effects in

Reported by a physician from Turkey on 2012-07-16

Patient:

Reactions: Asthma, Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-12-22
    End date: 2012-03-12

Velcade
    Dosage: unk
    Start date: 2012-03-22

Other drugs received by patient: Ceftriaxone Sodium; Tiotropium Bromide; Dexamethasone; Moxifloxacin; Methylprednisolone; Zometa; Tazobactam; Dexamethasone; Clarithromycin; Formoterol Fumarate



Possible Velcade side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13

Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)

Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-18
    End date: 2011-06-02

Dexamethasone
    End date: 2012-04-10

Prednisone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-12-20
    End date: 2011-06-09

Revlimid
    Administration route: Oral
    End date: 2012-05-01

Velcade
    End date: 2012-04-10

Velcade
    Dosage: .2714 milligram
    Indication: Multiple Myeloma
    Start date: 2010-12-12
    End date: 2011-06-02

Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride



Possible Velcade side effects in

Reported by a physician from Japan on 2012-07-09

Patient:

Reactions: Pneumonia, C-Reactive Protein Increased, Dehydration, Atrial Fibrillation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Panobinostat
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Velcade
    Dosage: 2.3 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-03-12

Other drugs received by patient: Mucosta; Amlodipine; Warfarin Sodium; Candesartan Cilexetil



Possible Velcade side effects in

Reported by a physician from Germany on 2012-07-06

Patient:

Reactions: Pneumonia, Neoplasm Malignant, Myelodysplastic Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Interferon
    Indication: Myelodysplastic Syndrome

Interferon
    Indication: Multiple Myeloma

Thalidomide
    Indication: Myelodysplastic Syndrome

Thalidomide
    Indication: Multiple Myeloma

Velcade
    Indication: Multiple Myeloma

Velcade
    Indication: Myelodysplastic Syndrome



Possible Velcade side effects in

Reported by a physician from Poland on 2012-06-25

Patient:

Reactions: Pneumonia, H1n1 Influenza

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade

Other drugs received by patient: Dexamethasone; Doxorubicin HCL



Possible Velcade side effects in

Reported by a physician from Germany on 2012-06-21

Patient:

Reactions: Pneumonia, Neoplasm Malignant, Myelodysplastic Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Interferon
    Indication: Multiple Myeloma

Interferon
    Indication: Myelodysplastic Syndrome

Thalidomide
    Indication: Multiple Myeloma

Thalidomide
    Indication: Myelodysplastic Syndrome

Velcade
    Indication: Multiple Myeloma

Velcade
    Indication: Myelodysplastic Syndrome



Possible Velcade side effects in

Reported by a physician from Turkey on 2012-06-20

Patient:

Reactions: Asthma, Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: unk
    Start date: 2012-03-22

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-12-22
    End date: 2012-03-12

Other drugs received by patient: Zometa; Tiotropium Bromide; Dexamethasone; Ceftriaxone Sodium; Tazobactam; Dexamethasone; Formoterol Fumarate; Clarithromycin; Moxifloxacin; Methylprednisolone



Possible Velcade side effects in

Reported by a physician from Germany on 2012-06-15

Patient:

Reactions: Pneumonia, Renal Failure, Pain, Urinary Retention, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade



Possible Velcade side effects in male

Reported by a physician from Sweden on 2012-06-13

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Pneumonia, Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Betamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-15
    End date: 2012-01-06

Betamethasone
    Administration route: Oral
    Start date: 2012-02-02
    End date: 2012-02-24

Revlimid
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-03-07

Velcade
    Indication: Multiple Myeloma
    Start date: 2011-12-15
    End date: 2012-01-05

Velcade
    Start date: 2012-02-02
    End date: 2012-02-23

Other drugs received by patient: Laxoberal; Digoxin; Robinul; Imovane; Polyethylene Glycol; Folic Acid; Novokeptol; Bisoprolol Fumarate; Betaprol; Oxazepam



Possible Velcade side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-13

Patient: male, weighing 87.7 kg (192.9 pounds)

Reactions: Pneumonia, Haemoptysis, Hypotension, Hyponatraemia, Fall, Sepsis Syndrome, Dehydration, Dizziness, Hypocalcaemia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 mg, 1/week
    Indication: Multiple Myeloma
    Start date: 2011-05-17

Zometa
    Dosage: 2 mg, unk
    Indication: Bone Loss
    Start date: 2011-05-13

Other drugs received by patient: Decadron; Dexamethasone; Coumadin; Fentanyl; Dulcolax; Fleet Enema / 00103901 /; Vicodin; Polyethylene Glycol; Digoxin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017